MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MAIA MAIA Biotechnology Inc.

Pre-Mkt 09-24 06:47:09 EDT

1.32

-0.05

-3.65%

盘前1.30

-0.02-1.33%

04:36 EDT

High1.36	Low1.30	Vol627.03K
Open1.35	D1 Closing1.37	Amplitude4.38%
Mkt Cap80.09M	Tradable Cap73.40M	Total Shares60.67M
T/O831.14K	T/O Rate1.13%	Tradable Shares55.61M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MAIA","market":"US","secType":"STK","nameCN":"MAIA Biotechnology Inc.","latestPrice":1.32,"timestamp":1790193600000,"preClose":1.37,"halted":0,"volume":627034,"hourTrading":{"tag":"盘前","latestPrice":1.3024,"preClose":1.32,"latestTime":"04:36 EDT","volume":360,"amount":474.825636,"timestamp":1790238990303,"change":-0.0176,"changeRate":-0.013333,"amplitude":0.020909},"delay":0,"changeRate":-0.036496350364963535,"floatShares":55605100,"shares":60671491,"eps":-0.608478,"marketStatus":"Pre-Mkt","change":-0.05,"latestTime":"09-24 06:47:09 EDT","open":1.35,"high":1.36,"low":1.3,"amount":831141.404925,"amplitude":0.043796,"askPrice":1.37,"askSize":1000,"bidPrice":1.19,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.608478,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790256600000},"marketStatusCode":1,"adr":0,"listingDate":1659067200000,"exchange":"AMEX","adjPreClose":1.32,"preHourTrading":{"tag":"盘前","latestPrice":1.3024,"preClose":1.32,"latestTime":"04:36 EDT","volume":360,"amount":474.825636,"timestamp":1790238990303,"change":-0.0176,"changeRate":-0.013333,"amplitude":0.020909},"postHourTrading":{"tag":"盘后","latestPrice":1.319,"preClose":1.32,"latestTime":"19:45 EDT","volume":6183,"amount":8133.2185,"timestamp":1790207126905,"change":-0.001,"changeRate":-0.000758,"amplitude":0.020758},"volumeRatio":0.7632048583081052},"requestUrl":"/m/hq/s/MAIA/tweets","defaultTab":"tweets","newsList":[{"id":"2669898284","title":"Maia Biotech Wins Spanish, Portuguese Regulatory Clearance to Screen Patients in THIO-104 Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669898284","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669898284?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:17","pubTimestamp":1790169458,"startTime":"0","endTime":"0","summary":"Maia Biotech wins Spanish, Portuguese regulatory clearance to screen patients in THIO-104 lung cancer trialMaia Biotechnology won regulatory clearance in Spain, Portugal to start screening for its Pha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL43t6JT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BCDF","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","SG9999014021.USD","SG9999014039.USD","MAIA","LU2210149790.SGD","SG9999014013.SGD","IE00BQXX3D17.EUR","LU0314104364.USD","BK4139","IE00BN0W2V16.EUR","BK4585","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4112","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","BK4588","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669898434","title":"Maia Biotechnology Expands Pivotal Phase 3 Thio-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669898434","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669898434?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:17","pubTimestamp":1790169420,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUABYXMWW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669898424","title":"Maia Biotechnology - Targets 100 Patients Dosed in Thio-104 by Year-End 2026; Interim Analysis in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2669898424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669898424?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:17","pubTimestamp":1790169420,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUABYXMWW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669333489","title":"MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal","url":"https://stock-news.laohu8.com/highlight/detail?id=2669333489","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669333489?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:17","pubTimestamp":1790169420,"startTime":"0","endTime":"0","summary":"THIO-104 advances toward key 2027 interim survival analysis CHICAGO, Sept.  23, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopha","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/23/3367552/0/en/maia-biotechnology-expands-pivotal-phase-3-thio-104-non-small-cell-lung-cancer-trial-into-spain-and-portugal.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2487616109.SGD","BK4139","L","LU0210528500.USD","BK4588","BK4585","LU0053666078.USD","BK4107","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142826","title":"Maia Biotech Says Phase 3 THIO-104 Trial in Third-Line NSCLC Enrolls 65 Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142826","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142826?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:47","pubTimestamp":1790081253,"startTime":"0","endTime":"0","summary":"Maia Biotech says Phase 3 THIO-104 trial in third-line NSCLC enrolls 65 patientsMaia Biotechnology reported progress in its pivotal Phase 3 THIO-104 trial of ateganosine as third-line therapy for adva","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL6XRdTd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","IE00BN0W2W23.USD","NDAQ","LU2095319765.USD","LU0314104364.USD","IE00BQXX3D17.EUR","BCDF","IE00BGHQF748.EUR","SG9999014039.USD","BK4112","MAIA","IE00BN0W2V16.EUR","SG9999014021.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","BK4585","SG9999014005.SGD","SG9999014013.SGD","BK4139","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142844","title":"Maia Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142844","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142844?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:47","pubTimestamp":1790081220,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nTUAC5MSVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669259142","title":"MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2669259142","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669259142?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:47","pubTimestamp":1790081220,"startTime":"0","endTime":"0","summary":"Strong pace of patient enrollment supports continued advancement toward regulatory milestones Most recent assessment of novel telomere targeting agent sequenced with a checkpoint inhibitor showed 90.5","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366372/0/en/maia-biotechnology-reports-pivotal-phase-3-clinical-trial-progress-in-advanced-non-small-cell-lung-cancer.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0274383776.USD","IE0031619046.USD","LU1815336091.USD","BK4139","LU2487616109.SGD","LU2065732104.USD","LU2089985449.USD","LU0210528500.USD","BK4157","IE00B66KJ199.SGD","BK4585","BK4588","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4097","PRGS","LU0757428866.USD","MAIA","BK4107","AEIS","L","LU0053666078.USD","LU2931357623.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667838979","title":"Maia Biotechnology Wins $2.3 Million NIH Grant for Phase 2 NSCLC Trial Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2667838979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667838979?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560937,"startTime":"0","endTime":"0","summary":"Maia Biotechnology wins $2.3 million NIH grant for Phase 2 NSCLC trial expansionMaia Biotechnology secured FDA clearance for an amended IND for ateganosine, citing improved manufacturing capabilities ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL3887By:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","LU2210149790.SGD","BK4139","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","MAIA","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4585","LU2095319765.USD","LU2210150020.SGD","SG9999014005.SGD","LU0314104364.USD","BK4588","IE00BGHQF748.EUR","SG9999014021.USD","IE00BN0W2V16.EUR","BK4112","SG9999014039.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00BQXX3D17.EUR","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667833983","title":"Maia Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667833983","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667833983?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA7Q1XS6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667498364","title":"MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667498364","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667498364?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560900,"startTime":"0","endTime":"0","summary":"Milestone follows FDA clearance of MAIA’s amended investigational new drug (IND) submission highlighting improved manufacturing capabilities and efficiencies U.S. expansion is funded by a $2.3 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/16/3363142/0/en/maia-biotechnology-doses-first-u-s-patient-in-ongoing-phase-2-non-small-cell-lung-cancer-clinical-trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPI","BK4107","BK4588","IND","ORR","L","MAIA","BK4139","LU0053666078.USD","LU2487616109.SGD","BK4585","LU0210528500.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667964259","title":"Maia Biotechnology Board Member Ramiro Guerrero Boosts Stake with USD 252,284 Share Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667964259","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667964259?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474531,"startTime":"0","endTime":"0","summary":"Maia Biotechnology board member Ramiro Guerrero boosts stake with USD 252,284 share buyMaia Biotechnology board member Ramiro Guerrero bought 185,078 common shares in open-market trades totaling about","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDL1S2Q9P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","BK4139","IE00B3QW5Z07.USD","SG9999014005.SGD","BK4585","BK4588","IE00B64PRP62.GBP","BCDF","SG9999014013.SGD","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BQXX3C00.GBP","BK4112","MAIA","LU2210149790.SGD","IE00BKPKM429.USD","SG9999014021.USD","IE00BQXX3F31.USD","SG9999014039.USD","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642552","title":"Maia Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642552","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642552?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA126B7H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667425506","title":"Maia Biotechnology - Directors and Officers Hold 21.34% Stake as of Sept 14, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667425506","media":"THOMSON REUTERS","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667425506?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA126B7H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667642250","title":"MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642250","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642250?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:15","pubTimestamp":1789474500,"startTime":"0","endTime":"0","summary":"CHICAGO, Sept.  15, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing immunotherapies fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362049/0/en/maia-biotechnology-announces-open-market-purchases-of-company-stock-by-long-standing-board-member-and-ceo.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","BK4588","LU0210528500.USD","LU2487616109.SGD","BK4107","BK4585","BK4139","L","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669028","title":"MAIA Biotechnology Director Makes Bold Insider Move With Fresh Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669028","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669028?lang=en_us&edition=fundamental","pubTime":"2026-09-15 10:02","pubTimestamp":1789437767,"startTime":"0","endTime":"0","summary":"New insider activity at MAIA Biotechnology, Inc. ( ($MAIA) ) has taken place on September 14, 2026. Director Ramiro Guerrero has increased his stak...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/maia-biotechnology-director-makes-bold-insider-move-with-fresh-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/maia-biotechnology-director-makes-bold-insider-move-with-fresh-stock-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667166939","title":"Maia Biotechnology Director Ramiro Guerrero Acquires 37,595 Common Shares Worth $49,511.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2667166939","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667166939?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:04","pubTimestamp":1789391056,"startTime":"0","endTime":"0","summary":"Maia Biotechnology director Ramiro Guerrero acquires 37,595 common shares worth $49,511.38Maia Biotechnology director Ramiro Guerrero bought 37,595 common shares at $1.32 each.His direct stake rose to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDLpyBbZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maia Biotechnology Director Ramiro Guerrero Acquires 37,595 Common Shares Worth $49,511.38","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666939885","title":"MAIA Biotechnology Presents Next-Generation Telomere-Targeting Cancer Drug Candidates at IRT 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666939885","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666939885?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:15","pubTimestamp":1789042522,"startTime":"0","endTime":"0","summary":"MAIA Biotechnology presents next-generation telomere-targeting cancer drug candidates at IRT 2026Maia Biotechnology disclosed preclinical results for next-generation telomere-targeting cancer candidat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL3JNPB4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","NDAQ","IE00BQXX3D17.EUR","BK4112","IE00BQXX3F31.USD","SG9999014039.USD","IE00BN0W2V16.EUR","MAIA","SG9999014013.SGD","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014021.USD","BK4585","IE00B3QW5Z07.USD","LU2210149790.SGD","LU0314104364.USD","BK4139","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","BCDF","IE00BN0W2W23.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664486983","title":"Maia Bio Director Ramiro Guerrero Buys 133,790 Shares Worth $185,114.90","url":"https://stock-news.laohu8.com/highlight/detail?id=2664486983","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664486983?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:17","pubTimestamp":1788293820,"startTime":"0","endTime":"0","summary":"Maia Bio director Ramiro Guerrero buys 133,790 shares worth $185,114.90Maia Biotechnology director Ramiro Guerrero bought 133,790 shares of common stock at prices ranging from $1.35 to $1.39.Guerrero’","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL1zPgtm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maia Bio Director Ramiro Guerrero Buys 133,790 Shares Worth $185,114.90","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662871655","title":"Maia Bio Director Ramiro Guerrero Acquires 1,794 Common Shares Worth $2,386.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2662871655","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662871655?lang=en_us&edition=fundamental","pubTime":"2026-08-26 19:57","pubTimestamp":1787745449,"startTime":"0","endTime":"0","summary":"Maia Bio director Ramiro Guerrero acquires 1,794 common shares worth $2,386.02Maia Biotechnology director Ramiro Guerrero bought 1,794 common shares at USD 1.33 each, a Form 4 filing shows.Guerrero’s ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL1dJ83B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maia Bio Director Ramiro Guerrero Acquires 1,794 Common Shares Worth $2,386.02","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MAIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662063862","title":"Maia Biotechnology Director Ramiro Guerrero Reports Purchase of 11,899 Common Shares for $16,301.63","url":"https://stock-news.laohu8.com/highlight/detail?id=2662063862","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662063862?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:10","pubTimestamp":1787602240,"startTime":"0","endTime":"0","summary":"Maia Biotechnology director Ramiro Guerrero reports purchase of 11,899 common shares for $16,301.63Maia Biotechnology director Ramiro Guerrero bought 11,899 common shares in open-market purchases at U","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4q7JKZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Maia Biotechnology Director Ramiro Guerrero Reports Purchase of 11,899 Common Shares for $16,301.63","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAIA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.MAIABiotech.com","stockEarnings":[{"period":"1week","weight":-0.0571},{"period":"1month","weight":-0.0222},{"period":"3month","weight":-0.0222},{"period":"6month","weight":0.0076},{"period":"1year","weight":-0.1373},{"period":"ytd","weight":-0.1373}],"compareEarnings":[{"period":"1week","weight":0.0182},{"period":"1month","weight":0.0057},{"period":"3month","weight":0.0456},{"period":"6month","weight":0.2109},{"period":"1year","weight":0.1577},{"period":"ytd","weight":0.126}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer. It is also developing second generation telomere targeting agents. MAIA Biotechnology, Inc. was incorporated in 2018 and is headquartered in Chicago, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.285723},{"month":2,"riseRate":0,"avgChangeRate":-0.06082},{"month":3,"riseRate":0.25,"avgChangeRate":-0.026788},{"month":4,"riseRate":0.5,"avgChangeRate":0.130553},{"month":5,"riseRate":0.75,"avgChangeRate":0.111873},{"month":6,"riseRate":0.5,"avgChangeRate":-0.089611},{"month":7,"riseRate":0.25,"avgChangeRate":-0.076547},{"month":8,"riseRate":0.2,"avgChangeRate":-0.109363},{"month":9,"riseRate":0.4,"avgChangeRate":0.001596},{"month":10,"riseRate":0.25,"avgChangeRate":-0.039628},{"month":11,"riseRate":0.25,"avgChangeRate":-0.189158},{"month":12,"riseRate":0.5,"avgChangeRate":0.077797}],"exchange":"AMEX","name":"MAIA Biotechnology Inc.","nameEN":"MAIA Biotechnology Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest MAIA Biotechnology Inc.(MAIA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"MAIA Biotechnology Inc.,MAIA,MAIA Biotechnology Inc.股票,MAIA Biotechnology Inc.股票老虎,MAIA Biotechnology Inc.股票老虎国际,MAIA Biotechnology Inc.行情,MAIA Biotechnology Inc.股票行情,MAIA Biotechnology Inc.股价,MAIA Biotechnology Inc.股市,MAIA Biotechnology Inc.股票价格,MAIA Biotechnology Inc.股票交易,MAIA Biotechnology Inc.股票购买,MAIA Biotechnology Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MAIA Biotechnology Inc.(MAIA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest MAIA Biotechnology Inc.(MAIA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}